Shots:
Over the years, CDMOs have significantly transformed the course of pharmaceutical and biopharmaceutical companies by leveraging their flexible manufacturing facilities and on-time drug deliveries
CDMOs help meet the ever-evolving needs of the healthcare sector by fostering the use of new-age technologies and advanced drug development and manufacturing processes
PharmaShots brings a condensed report on 20 Contract…
Shots:
Prescription drugs have an instrumental role in effectively controlling chronic diseases like heart-related conditions, diabetes, arthritis, hypertension, and cancer, among others. Unlike over-the-counter drugs, prescription drugs are advised not to be taken without the authorization of a doctor
In 2022, the global market size of prescription drugs was worth $1035.5B and is envisioned to…
Shots:
PharmaShots unravels the determinants of healthcare innovation with this rigorously prepared report on the Top 20 Countries in Healthcare Innovation. A meticulous report that encompasses all the significant aspects, necessary for well-rounded and innovative growth in the healthcare industry for a country
By deploying extensive market research, PharmaShots gathered, evaluated, organized, and analyzed the…
Shots:
Monoclonal antibodies are transforming therapeutics through their highly efficient targeting mechanisms. There is a wide range of uses for monoclonal antibodies, including diagnosis, therapy, and research
In 2021, the monoclonal antibody therapy market size was valued at $178.5B and is envisioned to reach $451.89B by 2028, displaying a CAGR of 14.1%. Humira was the…
Shots:
With more than 50% of ongoing clinical trials worldwide in oncology domains, cancer remains one of the leading causes of death worldwide. Oncology companies are steadfastly looking for innovative therapies to cure both hematologic and solid tumor cancer
The global oncology drug market size in 2022 was valued at $185B and is forecasted to…
Shots:
R&D (Research and Development) in the biopharma industry lays the foundation stone of innovative drugs. A robust R&D bolstered with new-age technological advances assures long-term sustainability in the future market
With a global expenditure of $238B in 2022, the figures are anticipated to reach $285B by 2028. In 2022, AbbVie ranked the top among…
Shots:
With the noble responsibility of ensuring a healthy society on their shoulders, biopharma companies focused on Immunology are diligently working to develop treatments, vaccines, antibodies, and drugs
The global Immunology market was valued at $97.93B in 2021 and is anticipated to reach $184.21B by 2029 with a CAGR of 8.5 percent. In 2022, AbbVie…
Shots:
Driven by a noble pursuit to ensure global health security, vaccines cater to the healthcare needs of millions and billions of people. With an instrumental role in containing the COVID-19 pandemic, immunization prevents more than 5 million deaths annually from conditions like diphtheria, tetanus, pertussis, influenza, and measles
With a global market size of…
Shots:
Transforming lives by leveraging cutting-edge technological advances, digital health companies have embarked on a journey to reshape the way we see and experience therapeutics
Digital health companies are fostering the use of highly innovative technologies in the healthcare system. In 2021, the global digital health therapeutics market was valued at $3.8B and is envisioned…
Shots:
On the trail of a healthy lifestyle, nutraceuticals have a crucial role to play. A portmanteau of nutrients and pharmaceuticals, nutraceuticals are colloquially known as medical foods
With a market size of $413B in 2021, the nutraceutical market value is forecasted to cross the threshold of $650B by 2030 by marking a remarkable CAGR…

